🚀 Welcome to the Script Hook V GitHub! 🎮 Unlock the full potential of GTA V with Script Hook V – the essential tool for running mods and custom scripts!

The first stemmed through a penetrative run and finish from Barrett in only the eighth minute, Brian Hayes set up Declan Dalton to fire the second six minutes later while Hayes would bat the third ...

With less than a minute on the clock, Shane O’Brien bore down on goal but Eibhear Quilligan superbly saved to deny the Kilmallock man. Limerick's Barry Murphy and Mark Rodgers of Clare battle ...

CLARE: Eibhear QUILLIGAN 8; Adam HOGAN 8, Darragh LOHAN 7, Conor LEEN 7; Cian GALVIN (0-1) 7, John CONLON 6, Cathal MALONE (0-1) 7; Tony KELLY (0-3) 8, Ryan TAYLOR 6; David FITZGERALD (0-2 ...

Good day, and thank you for standing by. Welcome to Madrigal Pharmaceuticals' Fourth Quarter and Full Year 2024 Earnings Conference Call. At this time, all participants are in listen-only mode.

On Wednesday, Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) reported two-year results from the open-label compensated MASH cirrhosis (F4c) arm of the Phase 3 MAESTRO-NAFLD-1 trial of Rezdiffra ...

Madrigal posted a Q4 loss of $2.71 per share, beating estimates, with sales of $103.22 million surpassing the $98.56 million consensus. Our government trade tracker caught Pelosi’s 169% AI winner.

Madrigal Pharmaceuticals, Inc.'s Rezdiffra, the first approved drug for MASH, showed strong sales growth, with Q4 net sales up 66% to $103.3m. Despite a net loss of $466m in 2024, Madrigal's cash ...

Madrigal reported better-than-expected Q4 results. The company also announced positive new two-year data from a phase 3 study of its MASH drug Rezdiffra. Madrigal reported fourth-quarter revenue ...

Madrigal Pharmaceuticals (MDGL) reported Q4 results and provided a 2-year update from the open-label metabolic dysfunction-associated steatohepatitis compensated F4 arm of the Phase 3 MAESTRO ...

Reports Q4 revenue $103.3M, consensus $97.81M. Bill Sibold, Chief Executive Officer of Madrigal, stated, “Looking back on 2024, I’m incredibly proud of what we accomplished. We secured FDA ...

WEST CONSHOHOCKEN, Pa. (AP) — WEST CONSHOHOCKEN, Pa. (AP) — Madrigal Pharmaceuticals Inc. (MDGL) on Wednesday reported a loss of $59.4 million in its fourth quarter. The West Conshohocken ...